Seeking Alpha

  Revance Therapeutics, Inc. - NASDAQ

10/20/2014, 5:48 AM ET
  • C.R. Jackson | Send Message 19 Mar

    Why Have Revance Therapeutics Shares More Than Doubled Since The February IPO? $RVNC
      RVNC vs. ETF Alternatives
      Company Description
      Revance Therapeutics Inc is a clinical stage specialty biopharmaceutical company, engaged in the development, manufacturing and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States